AMANDA VANTREASE: Open Payments
NPI 1619240413 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,428 in 100 payments from 39 companies in 2025. Trend: 2023 $1,238 · 2024 $1,898 · 2025 $2,428
Food & beverage: $2,329Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $318 |
| Merck Sharp & Dohme LLC | 9 | $261 |
| Janssen Biotech, Inc. | 6 | $248 |
| Regeneron Healthcare Solutions, Inc. | 14 | $202 |
| AstraZeneca Pharmaceuticals LP | 6 | $132 |
| PFIZER INC. | 6 | $117 |
| ABBVIE INC. | 5 | $116 |
| SEAGEN INC. | 1 | $99 |
| Aveo Pharmaceuticals, Inc. | 2 | $73 |
| BeOne Medicines USA, Inc. | 3 | $70 |
Products named: LIBTAYO, KEYTRUDA, RYBREVANT, KISQALI, CARVYKTI, PLUVICTO, VENCLEXTA, FOTIVDA.
Industry payments across TN — which companies pay providers there.
